Achema middle east

Xcellerex launches new bag-type XDR-10 single-use bioreactor

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Continuous Manufacturing Equipment: Adoption Barriers and Industry Readiness

While continuous manufacturing offers efficiency and quality benefits, high capital costs and technical barriers like PAT integration, feeder accuracy, and RTD modeling slow its widespread adoption in pharma.

Sustainable Laboratory Equipment Innovations Supporting Green Pharma Initiatives

As the pharmaceutical industry strives for carbon neutrality, the laboratory has become a focal point for sustainability efforts. This article highlights the latest innovations in eco-friendly equipment, from ultra-low temperature freezers to solvent recovery systems, demonstrating how green technology can reduce environmental impact without compromising scientific rigor.

Largest Vaccine Manufacturing Facility in Egypt Launched

Egypt has gone on to mark quite a prominent...
- Advertisement -

Xcellerex, a provider of manufacturing technologies, has launched new XDR-10 single-use bioreactor.

The new system, which is available in single-, twin-, triplet-, and quad-vessel configurations, is flexible to handle volumes from 4l to 10l.

The XDR-10 is an integral component of the Xcellerex FlexFactory modular biomanufacturing platform that leverages single-use technology and advanced process automation.

The new system features a low shear, high input-power impeller with optimized position which maximizes volume range and turndown ratio.

The XDR-10 can function as a production vessel in its own right, or become a scale-down tool or satellite platform for larger projects to be continued in larger bioreactors, according to the company.

The flexible platform enables biomanufacturers to speed up deployment of new manufacturing capacity with reduced capital costs and lowered risk.

Latest stories

Related stories

Continuous Manufacturing Equipment: Adoption Barriers and Industry Readiness

While continuous manufacturing offers efficiency and quality benefits, high capital costs and technical barriers like PAT integration, feeder accuracy, and RTD modeling slow its widespread adoption in pharma.

Sustainable Laboratory Equipment Innovations Supporting Green Pharma Initiatives

As the pharmaceutical industry strives for carbon neutrality, the laboratory has become a focal point for sustainability efforts. This article highlights the latest innovations in eco-friendly equipment, from ultra-low temperature freezers to solvent recovery systems, demonstrating how green technology can reduce environmental impact without compromising scientific rigor.

Largest Vaccine Manufacturing Facility in Egypt Launched

Egypt has gone on to mark quite a prominent...

UK Plans to Produce Cancer Treatment from Nuclear Waste

Bicycle Therapeutics has entered into a 15-year agreement with...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »